Prot# 156-10-292: An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized with Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Imp

Project: Research project

Project Details

StatusFinished
Effective start/end date11/4/10 → 11/4/13

Funding

  • Mapi USA, Inc. (156-10-292)
  • Otsuka America Pharmaceutical, Inc. (156-10-292)